First patient dosed in trial for novel dry AMD treatment PST-611

7th July 2025 Uncategorised 0

PulseSight begins phase 1 safety study of gene therapy for geographic atrophy

More: First patient dosed in trial for novel dry AMD treatment PST-611
Source: News